<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">224</article-id>
      <article-id pub-id-type="doi">10.31348/2021/36</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Paraneoplastic Optic Neuropathy as an Initial Clinical Manifestation of Small Cell Lung Cancer. A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Akbulut</surname>
            <given-names>Ersin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bayraktar</surname>
            <given-names>Havvanur</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tugcu</surname>
            <given-names>Betül</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>25</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <issue>6</issue>
      <elocation-id>5</elocation-id>
      <abstract>
        <p>Paraneoplastic optic neuropathy (PON) is a very rare condition. In this study, a case of PON is presented, with the first complaint by the patient being painless vision loss in one eye. In the follow-up of our case, optic neuropathy developed in the fellow eye. Electromyography examination performed due to diffuse body pain and motor loss in the left extremity was compatible with peripheral sensorimotor polyneuropathy. Lung biopsy was planned due to the EMG result and lymphadenopathy detection in thorax computed tomography (CT). The biopsy result of the patient was reported as nonspecific hyperplasia. As the patient’s complaints increased, a paraneoplastic antibody panel was requested and CV2 / CRMP5 antibody was found to be positive. Thereupon, as a result of the repeated biopsy, our patient was diagnosed with small cell lung cancer. We think that paraneoplastic optic neuropathy should be considered in the differential diagnosis in patients of advanced age, smokers, painless subacute vision loss, optic disc swelling, and research in this direction should be insisted on, as in our case.</p>
      </abstract>
      <kwd-group>
        <kwd>paraneoplastic optic neuropathy</kwd>
        <kwd>small cell lung cancer</kwd>
        <kwd>CV2/CRMP5 antibodies</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R5561">
        <mixed-citation>Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006;33(3):270-298. doi: 10.1053/j. seminoncol.2006.03.008<pub-id pub-id-type="doi">10.1053/j</pub-id></mixed-citation>
      </ref>
      <ref id="R5562">
        <mixed-citation>Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;58(5):430-458. doi: 10.1016/j.survophthal.2012.09.001<pub-id pub-id-type="doi">10.1016/j.survophthal.2012.09.001</pub-id></mixed-citation>
      </ref>
      <ref id="R5563">
        <mixed-citation>Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1(5):294-</mixed-citation>
      </ref>
      <ref id="R5564">
        <mixed-citation>Damek DM. Paraneoplastic Retinopathy/Optic Neuropathy. Curr Treat Options Neurol. 2005;7(1):57-67. doi: 10.1007/s11940-005-0007-1<pub-id pub-id-type="doi">10.1007/s11940-005-0007-1</pub-id></mixed-citation>
      </ref>
      <ref id="R5565">
        <mixed-citation>Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49(2):146-154.</mixed-citation>
      </ref>
      <ref id="R5566">
        <mixed-citation>Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543-1554. doi: 10.1056/ NEJMra023009</mixed-citation>
      </ref>
      <ref id="R5567">
        <mixed-citation>Pillay N, Gilbert JJ, Ebers GC, Brown JD. Internuclear ophthalmoplegia and “optic neuritis”: paraneoplastic effects of bronchial carcinoma. Neurology. 1984;34(6):788-791. doi: 10.1212/ wnl.34.6.788</mixed-citation>
      </ref>
      <ref id="R5568">
        <mixed-citation>Malik S, Furlan AJ, Sweeney PJ, Kosmorsky GS, Wong M. Optic neuropathy: a rare paraneoplastic syndrome. J Clin Neuroophthalmol. 1992;12(3):137-141.</mixed-citation>
      </ref>
      <ref id="R5569">
        <mixed-citation>Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery &amp;amp; Psychiatry. 1996;61(3):270-278. doi: 10.1136/jnnp.61.3.270<pub-id pub-id-type="doi">10.1136/jnnp.61.3.270</pub-id></mixed-citation>
      </ref>
      <ref id="R5570">
        <mixed-citation>Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48(1):12-38. doi: 10.1016/s0039-6257(02)00416-2<pub-id pub-id-type="doi">10.1016/s0039-6257(02)00416-2</pub-id></mixed-citation>
      </ref>
      <ref id="R5571">
        <mixed-citation>Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003;54(1):38-50. doi: 10.1002/ana.10587<pub-id pub-id-type="doi">10.1002/ana.10587</pub-id></mixed-citation>
      </ref>
      <ref id="R5572">
        <mixed-citation>Nakajima M, Uchibori A, Ogawa Y, et al. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer. Intern Med. 2018;57(11):1645-1649. doi: 10.2169/internalmedicine.9736-17<pub-id pub-id-type="doi">10.2169/internalmedicine.9736-17</pub-id></mixed-citation>
      </ref>
      <ref id="R5573">
        <mixed-citation>doi: 10.1016/s1474-4422(02)00135-7.<pub-id pub-id-type="doi">10.1016/s1474-4422(02)00135-7</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
